Speaker Interview with Lorenzo Pasquali for 4th Annual MarketsandMarkets Epigenetics Congress

Speaker Interview with Lorenzo Pasquali for 4th Annual MarketsandMarkets Epigenetics Congress

London, UK July 23, 2019 – MarketsandMarkets recently interviewed Lorenzo Pasquali, Group Leader, Endocrine Regulatory Genomics Laboratory IGTP, Spain regarding the 4th Annual MarketsandMarkets Epigenetics Congress, taking place on 3-4 October 2019 at Radisson Blu Edwardian, Grafton, London, UK. Dr. Lorenzo Pasquali is Group Leader of the Endocrine Regulatory Genomics laboratory at IGTP, Barcelona, Spain . His studies helped to map the epigenetic landscape of the insulin producing pancreatic islet cells resulting in milestone publications that opened the path to understand genomic regulation of the islets of Langerhans and shed…

Read More

AveXis Directs to Catalent’s Paragon for Extra Gene Therapy Producing Capacity

AveXis Directs to Catalent’s Paragon for Extra Gene Therapy Producing Capacity

Catalent has approved AveXis that, a Novartis Company to use its brand-new commercial manufacturing center near Baltimore-Washington International Airport as an extra site production site for its spinal muscular atrophy (SMA) gene therapy Zolgensma® (onasemnogene abeparvovec-xioi). A collaboration contract was signed by Catalent and AveXis to ensure long term strategic agreement but has not been disclosed yet. AveXis will use the dedicated production space within Paragon’s Harmans, MD, facility, a 151,000-square-foot old warehouse that Paragon changed into a contract developing and a manufacturing site which opened in April. Andy Stober,…

Read More

Genmab Partners Raised $503M U.S. IPO on Cancer Antibodies with BliNK Biomedical

Genmab Partners Raised $503M U.S. IPO on Cancer Antibodies with BliNK Biomedical

Genmab through collaboration with Blink biomedicals raised a whopping $503 Million through an American initial public offering (IPO) all this got revealed on Friday during an event. Genmab also launched an up to $200 million-per-product cancer therapy with Blink biomedicals. Blink biomedicals got a license approved by Genmab exclusively for antibodies targeting CD47, which Genmab plans to combine with its duo body platform technology to produce new bispecific antibodies for fighting cancer. Genmab CEO Jan van de Winkel, Ph.D. gave his words about this CD47 stating that “CD47 has shown…

Read More

Safety in Industry 4.0 – Are you prepared for the Automation?

Safety in Industry 4.0 – Are you prepared for the Automation?

With the rapid change of the modern world into an ‘Industry 4.0’ economy, it can be said that the change is somewhat similar to the Industrial revolution of the 18th century. Industries have undergone a significant change in terms of production and optimization of the whole process, things like machine learning; AI i.e. artificial intelligence and automation are the primary cause. As the process is getting better and mature there is the introduction of cyber-physical systems, cloud computing, and cognitive/behavioral computing all this gives rise to certain specific problems which…

Read More

Bravatek Solutions Signs Partnership Agreement for IIOT Technology

Bravatek Solutions Signs Partnership Agreement for IIOT Technology

AUSTIN, Texas, June 25, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Bravatek Solutions, Inc. (OTC Pink: BVTK) (“Bravatek” or the “Company”) declared that it entered into an arrangement with MC smart controls, Inc. to display and advertise its IIOT technology on an absolute basis to customers like policymakers and military. Along with this, BVTK will advertise its products on a non-absolute basis to manufacturers of systems that have a demand to be connected to the Internet. IIOT goes far beyond the regular customer devices because of its connection via communication…

Read More

Microba Partners with Korean Company Macrogen to Develop Global Microbiome Service Offering

Microba Partners with Korean Company Macrogen to Develop Global Microbiome Service Offering

Australian biotech giant Microba has made an alliance with Macrogen to develop microbiome research services for the offshore market. An MOU has got signed at the Macrogen Headquarters in Seoul on 14 March 2019 defining all the partnership terms and condition. Through this MOU, Macrogen and Microba will establish a close cooperation system. With this partnership, they will try to penetrate into the microbiome market of Korea and other nations Macrogen is a significant Korean company which has a market capitalization of 350m USD and annual revenues touching 100m USD….

Read More

Deal of Zymeworks up to $1.2bn Announced by J&J Biospecific Antibody

Deal of Zymeworks up to $1.2bn Announced by J&J Biospecific Antibody

Johnson & Johnson and Zymeworks have done a deal by which Johnson & Johnson will pay Zymework $50m to license it as well as to develop around six therapeutic agents. Jansen will have all the ownership and responsibilities for all research development and commercialization of the outcome. According to Zymework’s CEO Ali Tehrani, the license is not exclusive for any targets. Zymeworks will receive a potential $282m in development and up to $1.12bn in milestone payments and royalties. Jansen has also the option to develop two additional bispecific programs subject…

Read More

MarketsandMarkets Industry 4.0 Conference: Cyber Security & IIoT Invites Cyber Security & IIoT Experts and Leaders in Chicago

MarketsandMarkets Industry 4.0 Conference: Cyber Security & IIoT Invites Cyber Security & IIoT Experts and Leaders in Chicago

Chicago, May 31 – Focused on the impact of two technologies i.e, Cyber Security & IIoT, on manufacturers, MarketsandMarkets Industry 4.0 Conference: Cyber Security & IIOT, is addressing a series of application-based illustrations and discussions to map the future possibility of trends in the manufacturing world. Discussing solutions to the challenges faced, see the future of manufacturing from leading experts and industry leaders presenting their proven strategies and solutions. The 2-day conference starting from September 23, 2019 to September 24, 2019 in Chicago – USA, will provide a platform to…

Read More

Discussing Challenges and Opportunities in AI & Fintech at The 2nd Edition MarketsandMarkets AI & Fintech Conference.

Discussing Challenges and Opportunities in AI & Fintech at The 2nd Edition MarketsandMarkets AI & Fintech Conference.

MarketsandMarkets is organizing its 2nd Edition AI & Fintech Conference in San Francisco on May 16-17, 2019 discussing the hidden opportunity for FinTech, the impact of AI on FinTech and how AI is unlocking new lending opportunities. With attendance of experts from Banks, Hedge Funds, Insurance companies, Financial institutions, Stock Broking firms, Wealth Management firms etc. this two-day event will host use cases of Fintech, Blockchain from leading banks, financial services companies and technology providers along with innovative & emerging FinTech start-ups. San Francisco, April 2– MarketsandMarkets Presents to you…

Read More

MarketsandMarkets Competitive and Market Intelligence Summit – Speaker Interview – Jessica Williams

MarketsandMarkets Competitive and Market Intelligence Summit – Speaker Interview – Jessica Williams

Chicago, US March 29, 2019 – MarketsandMarkets recently interviewed Jessica Williams, Research and Strategy, Market & Talent Intelligence, Microsoft regarding MarketsandMarkets Competitive and Market Intelligence Summit taking place on June 13-14, 2019 in Chicago, USA. Jessica is a strategist who loves to build the latest approaches for talent and business decision. Her specialities are Market analysis, consulting, business intelligence etc. 1) What is the significance of Market and Competitive Intelligence role in an organization in today’s era? A – Market Intelligence is crucial for a company’s success in today’s environment. …

Read More